Huahong花红品牌怎么样 申请店铺

更新时间:2024-10-28
Huahong花红是哪个国家的品牌?「Huahong花红」是 广西壮族自治区花红药业股份有限公司 旗下著名品牌。该品牌发源于广西,由创始人韦飞燕在1982期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
Huahong花红怎么样

广西花红药业股份有限公司集药材基地、科研、生产、销售为一体,是国家重点中成药企业,始建于20世纪70年代初。2002年完成国有改制,与上海复星医药(集团)股份有限公司进行合资合作,充分运用复星医药的资金、技术、管理等综合资源,在现代中药、药材种植、医药流通、资本运营等领域实现共赢;2005年花红品牌向健康产业延伸,建立子公司花红俱乐部。

花红药业拥有“花红”驰名保护和40多项国家专利,改制后投入巨资改造现代中药的软硬件设施,通过了GMP、CGMP,达到国际注册标准,是广西区技术中心、国家级高新技术企业。

花红药业GMP生产基地占地200亩、年生产能力达10亿元以上,生产能力规模居广西中成药行业首位。公司拥有以妇科产品为主的中成药50多个品种,包括国家中药保护品种花红片、花红颗粒、葛根芩连丸、消肿止痛酊,以及花红随身洁、养血当归糖浆等。其中独家品种花红片、花红颗粒、花红胶囊、消肿止痛酊、葛根芩连丸、解毒生肌膏入选国家《药品目录(2009年版)》。治疗流感、腹泻的独家产品葛根芩连丸是全国中医院急诊必备用药,由于具有抗病毒、起效快特点,多次在国家发生大的疫情时,被国家卫生部推荐为诊疗用药。主导产品花红片、消肿止痛酊是全国治疗妇科炎症用药和外用镇痛酊剂类用药的知名品牌。

花红药业奉行“关心健康,爱护家庭”的宗旨,秉承“坦诚、开放、严谨、感恩”的企业理念,致力于女性健康事业,为改善和提高女性健康水平,提供专业化的优质药品和服务,发展以品牌为核心的妇科产品群,努力成为中国乃至全球女性用药的一流企业和女性健康专家。

Guangxi Huahong Pharmaceutical Co., Ltd. is a national key Chinese patent medicine enterprise, which integrates the base of medicinal materials, scientific research, production and sales. It was founded in the early 1970s. In 2002, the state-owned restructuring was completed, and a joint venture cooperation was carried out with Shanghai Fosun Pharmaceutical (Group) Co., Ltd. to make full use of Fosun Pharmaceutical's capital, technology, management and other comprehensive resources to achieve a win-win situation in the fields of modern Chinese medicine, herbal medicine planting, pharmaceutical circulation, capital operation, etc.; in 2005, Huahong brand extended to the health industry and established a subsidiary Huahong club. Huahong Pharmaceutical Co., Ltd. is well-known for its "Huahong" protection and more than 40 national patents. After the reform, it invested heavily in the reconstruction of the software and hardware facilities of modern Chinese medicine, passed GMP and cGMP, and reached the international registration standard. It is a technology center of Guangxi district and a national high-tech enterprise. Huahong pharmaceutical GMP production base covers an area of 200 mu, with an annual production capacity of more than 1 billion yuan, ranking first in Guangxi's proprietary Chinese medicine industry. The company has more than 50 kinds of traditional Chinese medicine mainly for gynecology products, including Huahong tablet, Huahong granule, Gegen Qinlian pill, Xiaozhong Zhitong tincture, Huahong portable cleaning, blood nourishing Angelica syrup, etc. Among them, the exclusive varieties of Huahong tablet, Huahong granule, Huahong capsule, Xiaozhongzhitong tincture, Gegenqinlian pill and Jiedu Shengji ointment were selected into the National Drug Catalogue (2009 Edition). Gegen Qinlian pill, an exclusive product for the treatment of influenza and diarrhea, is an essential medicine for emergency treatment in Chinese medicine hospitals. Because of its antiviral and quick effect, it has been recommended by the Ministry of health as a medicine for diagnosis and treatment when there are many large epidemics in the country. Huahong tablet and Xiaozhongzhitong tincture, the leading products, are well-known brands for the treatment of gynecological inflammation and external analgesic tincture. Huahong pharmaceutical adheres to the tenet of "caring for health, caring for family", adheres to the enterprise concept of "honesty, openness, preciseness and gratitude", devotes itself to the cause of women's health, provides professional high-quality drugs and services for improving and improving women's health level, develops the gynaecological product group with brand as the core, and strives to become the first-class enterprise and women's medicine in China and even in the world Health experts.

本文链接: https://brand.waitui.com/f7cc93a62.html 联系电话:0772-3993606

千城特选小程序码

7×24h 快讯

中央汇金三季度继续出手,3000亿元增持五大宽基ETF

最新披露的基金2024年三季报证实,在三季度的震荡行情中,中央汇金资产管理有限责任公司(下称“中央汇金”)继续增持ETF,仅4只沪深300ETF和华夏上证50ETF,就耗资约3000亿元。从年内的资金流向来看,大量资金借道ETF入市,ETF净申购额接近8800亿元,仅华泰柏瑞沪深300ETF净申购额就高达2002亿元。(上证报)

22分钟前

氧化铝价格创近十年新高,供给收紧局面难改

自10月22日盘中一度突破5000元/吨关口后,国内期货市场上氧化铝主力合约2411价格近日已稳定在5100元/吨上方,刷新历史高点,较一年前这一新品种上市之初的价格近乎翻番。而现货市场上,当前氧化铝价格也已逼近5000元/吨,为近十余年来高位。作为电解铝重要的生产原材料,氧化铝价格持续走高,已显著冲击了铝企的盈利水平。相较今年5月份,铝企单吨盈利已缩减超千元,个别企业甚至陷入亏损区间。氧化铝价格高位运行,对下游形成冲击,产业链负反馈效应渐显。不过分析人士多认为,当前氧化铝供给端未释放预期,市场供需矛盾尚存,短期价格强势格局或难改。(证券时报)

22分钟前

逾800家公司披露股东回报规划,稳步提升A股估值

近期,A股公司分红积极性持续高涨,分红金额屡创新高。统计发现,今年合计已有813家公司披露了三年股东回报规划并锁定最低分红率,为近四年来最多。年化估算预计将有957家公司披露最低分红方案,有望刷新年度历史最高纪录。同时,大量龙头公司展现出引领风范。数据显示,今年以来已经有4家千亿市值公司披露了未来三年每年不低于30%分红率的股东回报规划,此前五年合计只有3家千亿市值公司披露了类似承诺。发布股东回报规划的上市公司数量大幅增长,表明A股分红透明度进一步加大,有助于稳步提升A股估值。(证券时报)

22分钟前

波音公司据悉计划最快在周一将进行超过150亿美元融资

波音公司计划最快在周一将进行超过150亿美元的融资。(财联社)

22分钟前

自营业务驱动,多数券商三季度业绩回暖

10月25日,东方财富、湘财股份、国元证券、国盛金控等上市券商及上市券商主体纷纷发布三季度“成绩单”。10月23日,首创证券披露首份券商三季报。总体来看,首批券商三季报业绩出现分化,有的前三季度营收净利润双双实现同比正增长,有的业绩小幅下滑。不过,多数券商第三季度业绩普遍回暖。分业务来看,自营业务仍是券商业绩增长主要驱动因素,如东方财富、首创证券等自营业务均实现同比增长。(上证报)

22分钟前

本页详细列出关于Huahong花红的品牌信息,含品牌所属公司介绍,Huahong花红所处行业的品牌地位及优势。
咨询